BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Innovation Works - ECPv6.8.2.1//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Innovation Works
X-ORIGINAL-URL:https://www.innovationworks.org
X-WR-CALDESC:Events for Innovation Works
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/New_York
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20220313T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20221106T060000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20220315T080000
DTEND;TZID=America/New_York:20220315T080000
DTSTAMP:20241129T021320
CREATED:20220118T141402Z
LAST-MODIFIED:20220302T183855Z
UID:4750-1647331200-1647331200@www.innovationworks.org
SUMMARY:TrialSpark at BioBreakfast
DESCRIPTION:Next Stage: Trial Spark \nTrialSpark is a technology-driven pharma company that runs end-to-end clinical trials\, focused on bringing new treatments to patients faster and more efficiently. TrialSpark has built a technology platform that optimizes all aspects of a clinical trial\, enabling more efficient trial design\, faster trial completion\, and higher quality trial data capture. With these unique trial capabilities and an investment mandate focused on clinical-stage assets\, we are looking to in-license and co-develop drug programs through in-house development\, joint ventures\, and NewCos. Early in their development\, the company participated in AlphaLab\, and they are coming back to Pittsburgh to share their story and spread the word about their product. \nTrialSpark will be speaking at BioBreakfast sponsored by Innovation Works.
URL:https://www.innovationworks.org/event/next-stage-trialspark/
LOCATION:PA
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20220323T093000
DTEND;TZID=America/New_York:20220323T113000
DTSTAMP:20241129T021320
CREATED:20220302T155622Z
LAST-MODIFIED:20220310T131847Z
UID:4861-1648027800-1648035000@www.innovationworks.org
SUMMARY:10th Annual IW & EY Investment Report
DESCRIPTION:Innovation Works and Ernst & Young LLP (EY US) are proud to present our tenth annual review of Pittsburgh’s technology investment landscape. This report provides a comprehensive review of investment and exit activity in the Pittsburgh region from 2011—2021. \nStarting at 9:30 a.m. on March 23\, Rich Lunak\, IW President & CEO\, and Leon Hoffman\, Managing Partner of EY Pittsburgh\, will offer brief\, virtual comments highlighting what’s happening in the Pittsburgh region from an investment perspective. Then we’ll feature an intimate discussion with Rimsys Founder & CEO James Gianoutsos\, Andrew Hedin Partner at Bessemer Venture Partners and IW Chief Investment Officer Ven Raju. \nIn 2021\, Rimsys closed on a $16 million series A financing round led by legendary Bessemer Venture Partners to support the company’s product line and geographic expansion. Learn more from James and Ven about appealing to investors\, what makes Pittsburgh so interesting for venture capitalists and what happens after you land that deal and put the money to work.
URL:https://www.innovationworks.org/event/10th-annual-iw-ey-investment-report/
LOCATION:PA
END:VEVENT
END:VCALENDAR